PeptidesReview.orgBrowse vendors

Vendor evidence review

Active

Simple Peptide

Three sampled Simple Peptide reports reproduced on Freedom Diagnostics Testing's document host with accession numbers, lot identifiers, identity, purity, measured content, and endotoxin-threshold results. Retail provenance, chain of custody, and sterility for the sampled reports were not verified.

An active storefront and searchable COA archive were observed on August 26, 2026. This observation does not establish continuous fulfillment or future availability.

Last reviewed August 26, 2026Status checked August 26, 2026Evidence profile, not an endorsementScientific reviewer status pending

Answer in under 30 seconds

Quick verdict

Three sampled Simple Peptide reports reproduced on Freedom Diagnostics Testing's document host with accession numbers, lot identifiers, identity, purity, measured content, and endotoxin-threshold results. Retail provenance, chain of custody, and sterility for the sampled reports were not verified.

A score summarizes only criterion outcomes backed by published evidence. Unknown and not-tested criteria are excluded, then shown in the coverage count.
Overall evidence83%9 of 12 criteria scored
COA transparency83%3 of 4 criteria scored
Testing evidence88%4 of 5 criteria scored

What we verified

  • Three selected accession records reproduced on the laboratory-controlled document host.
  • The selected reports print Simple Peptide as the client and include accession and lot identifiers.
  • The sampled records state identity, chromatographic purity, measured content, and endotoxin-threshold results.

What we could not verify

  • Independent sample selection, retail provenance, or chain of custody.
  • Sterility for the three sampled March 2026 reports.
  • An independent accreditation scope for the methods shown.
  • Completeness of the public archive or coverage of every current lot.

Major strengths

  • Searchable COA archive using product, lot, or accession identifiers.
  • Selected reports can be reproduced on a laboratory-controlled host.
  • Identity, purity, content, and endotoxin fields are reported separately.

Major concerns

  • PeptidesReview did not control sample selection or chain of custody.
  • The sampled reports do not state a sterility result.
  • Passing endotoxin-threshold replicates are shown without a numeric result or complete acceptance basis.

Criterion-level audit

Evidence scorecard

Every status remains visible so missing evidence cannot hide inside a composite percentage.

CriterionFindingProvenanceEvidence detail
Laboratory identity verificationVerifiedThird-party laboratory evidence

Three selected accessions reproduced on Freedom Diagnostics Testing's document host, and the laboratory maintains a public lookup service.

Limitation: Laboratory identity verification does not establish accreditation, sample selection, custody, or retail provenance.
Report authenticityVerifiedThird-party laboratory evidence

Accessions 2603190343, 2603190349, and 2603190361 reproduced as laboratory-hosted PDFs naming Simple Peptide as the client.

Limitation: Authenticity applies to the selected documents, not the completeness of the vendor archive.
Batch or lot traceabilityPartially verifiedThird-party laboratory evidence

The selected reports print lot identifiers and the vendor provides a searchable lot and accession archive.

Limitation: PeptidesReview did not match a purchased retail vial to the printed lots or observe chain of custody.
Peptide identity testingVerifiedThird-party laboratory evidence

The three selected reports state mass-spectrometry-supported identity results for the named analytes.

Limitation: The findings apply only to the submitted samples and printed method language.
Purity testingVerifiedThird-party laboratory evidence

All three selected reports state HPLC-UV purity results ranging from 99.393% to 99.858%.

Limitation: Chromatographic purity does not establish quantity, sterility, safety, or future-lot performance.
Quantity testingVerifiedThird-party laboratory evidence

All three selected reports state measured net peptide content with units.

Limitation: Vendor-controlled submission does not establish ordinary retail provenance.
Sterility testingNot verifiedThird-party laboratory evidence

The three sampled March 2026 reports do not state a sterility result.

Limitation: This does not establish that the vendor has never performed sterility testing on other lots.
Endotoxin testingPartially verifiedThird-party laboratory evidence

Each selected report prints two passing endotoxin-threshold replicates.

Limitation: The selected reports do not print a numeric endotoxin result or the complete acceptance basis. An endotoxin result does not establish sterility or general safety.
Raw analytical data availabilityNot verifiedThird-party laboratory evidence

The public PDFs show summary chromatograms and mass spectra, but not raw files, integrations, calculations, or full validation records.

Limitation: This finding is limited to the public material reviewed on 2026-08-26.
Testing recencyVerifiedThird-party laboratory evidence

The three selected reports were issued on March 21, 2026 and remained accessible on the review date.

Limitation: Recency does not establish future-lot performance.
Vendor transparencyPartially verifiedVendor-provided evidence

Simple Peptide provides a searchable COA archive by product, lot, or accession and exposes laboratory report links.

Limitation: Archive completeness and coverage of current inventory were not independently counted.
Independent purchase or testing evidenceNot verifiedOrigin not determined

PeptidesReview did not purchase, handle, or submit a sample and did not control chain of custody.

Limitation: The vendor or submitter controlled the tested samples.

Report authenticity

Verified

Accessions 2603190343, 2603190349, and 2603190361 reproduced as laboratory-hosted PDFs naming Simple Peptide as the client.

Batch or lot traceability

Partially verified

The selected reports print lot identifiers and the vendor provides a searchable lot and accession archive.

Raw analytical data availability

Not verified

The public PDFs show summary chromatograms and mass spectra, but not raw files, integrations, calculations, or full validation records.

Testing recency

Verified

The three selected reports were issued on March 21, 2026 and remained accessible on the review date.

Learn how to audit a peptide COA

Testing evidence

Reports tied to this vendor

A report is shown only when its source, scope, date, and limitations are recorded.

Third-party laboratory record

Simple Peptide Cagrilintide report 2603190349

Laboratory
Freedom Diagnostics Testing
Report date
2026-03-21
Batch or lot
CAG10-032026-1
Claimed quantity
10 mg
Measured quantity
9.87 mg
Chain of custody
notDocumented
Open the source report

Third-party laboratory record

Simple Peptide BPC-157 report 2603190361

Laboratory
Freedom Diagnostics Testing
Report date
2026-03-21
Batch or lot
BPC15-01092026-J
Claimed quantity
15 mg
Measured quantity
16.75 mg
Chain of custody
notDocumented
Open the source report

Third-party laboratory record

Simple Peptide BPC-157 / TB-500 report 2603190343

Laboratory
Freedom Diagnostics Testing
Report date
2026-03-21
Batch or lot
BPTB20-032026-1
Claimed quantity
BPC-157 10 mg / TB-500 10 mg
Measured quantity
BPC-157 10.67 mg / Thymosin Beta-4 9.68 mg
Chain of custody
notDocumented
Open the source report

Simple Peptide publishes a searchable COA archive and exposes lot and accession identifiers that can be checked against selected laboratory-hosted documents. The reviewed sample does not establish archive completeness, current-inventory coverage, independent sample selection, or a qualified accreditation scope.

See how transparency evidence is evaluated

Comparable vendors

Continue with objective comparisons.

Ion PeptideAn evidence review of Ion Peptide's public reports, laboratory identity, batch traceability, testing methods, and unresolved verification gaps.Verified PeptidesAn evidence review of Verified Peptides' batch reports, Janoshik verification process, testing scope, transparency, and unresolved evidence gaps.

Final evidence-based assessment

The selected document packet is comparatively auditable because three accessions reproduced on the laboratory's own document host and preserve client, lot, identity, purity, and measured-content fields. The assessment remains limited to vendor-submitted samples. It does not establish sterility for the sampled reports, retail provenance, chain of custody, manufacturing controls, safety, or future-lot performance.

Commercial relationship

PeptidesReview has no commercial relationship, affiliate arrangement, paid placement, or purchasing incentive involving Simple Peptide.

Right to reply

Simple Peptide was not contacted before publication. The profile will be corrected if documented evidence changes a material finding.

Sources and verification records

  1. Vendor-provided evidenceVendor-provided materialAccessed Aug 26, 2026
  2. Simple Peptide sample COA 2603190343, Freedom Diagnostics, hosted by Simple Peptide
    Vendor-provided evidenceLaboratory documentReport or publication date Mar 21, 2026Accessed Aug 26, 2026
  3. Freedom Diagnostics Testing homepage, Freedom Diagnostics Testing
    Third-party laboratory evidenceOtherAccessed Aug 26, 2026
  4. Freedom report 2603190343, Freedom Diagnostics Testing
    Third-party laboratory evidenceLaboratory documentReport or publication date Mar 21, 2026Accessed Aug 26, 2026
  5. Freedom report 2603190349, Freedom Diagnostics Testing
    Third-party laboratory evidenceLaboratory documentReport or publication date Mar 21, 2026Accessed Aug 26, 2026
  6. Freedom report 2603190361, Freedom Diagnostics Testing
    Third-party laboratory evidenceLaboratory documentReport or publication date Mar 21, 2026Accessed Aug 26, 2026

PeptidesReview reproduced three selected accession records on Freedom Diagnostics Testing's document host. The selected records include lot identifiers, identity results, chromatographic purity, measured content, and reported endotoxin-threshold results. Retail provenance, chain of custody, sterility for the sampled reports, and independent accreditation scope remain unverified.

Vendor profile sources

  1. Vendor-provided evidenceVendor-provided materialAccessed Aug 26, 2026
  2. Simple Peptide sample COA 2603190343, Freedom Diagnostics, hosted by Simple Peptide
    Vendor-provided evidenceLaboratory documentReport or publication date Mar 21, 2026Accessed Aug 26, 2026
  3. Freedom Diagnostics Testing homepage, Freedom Diagnostics Testing
    Third-party laboratory evidenceOtherAccessed Aug 26, 2026
  4. Freedom report 2603190343, Freedom Diagnostics Testing
    Third-party laboratory evidenceLaboratory documentReport or publication date Mar 21, 2026Accessed Aug 26, 2026
  5. Freedom report 2603190349, Freedom Diagnostics Testing
    Third-party laboratory evidenceLaboratory documentReport or publication date Mar 21, 2026Accessed Aug 26, 2026
  6. Freedom report 2603190361, Freedom Diagnostics Testing
    Third-party laboratory evidenceLaboratory documentReport or publication date Mar 21, 2026Accessed Aug 26, 2026

Read the complete methodology